Total Payments
$1,851
2024 Payments
$187.32
Companies
24
Transactions
75
Medicare Patients
1,565
Medicare Billing
$119,334
Payment Breakdown by Category
Food & Beverage$1,851 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,851 | 75 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceuticals, Inc. | $384.24 | 12 | $0 (2021) |
| Amgen Inc. | $205.51 | 4 | $0 (2024) |
| ABBVIE INC. | $205.33 | 10 | $0 (2024) |
| Biogen, Inc. | $116.51 | 3 | $0 (2022) |
| Lilly USA, LLC | $99.10 | 5 | $0 (2022) |
| GENZYME CORPORATION | $79.11 | 4 | $0 (2022) |
| SK Life Science, Inc. | $78.97 | 3 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $74.12 | 4 | $0 (2022) |
| Allergan, Inc. | $67.35 | 3 | $0 (2022) |
| Lundbeck LLC | $66.13 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $187.32 | 3 | Amgen Inc. ($166.81) |
| 2023 | $19.56 | 1 | AbbVie Inc. ($19.56) |
| 2022 | $695.44 | 30 | Biogen, Inc. ($86.40) |
| 2021 | $949.02 | 41 | Biohaven Pharmaceuticals, Inc. ($384.24) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/04/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $74.61 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/03/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $92.20 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/02/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2022 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Neuroscience | ||||||
| 03/30/2022 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: EPILEPSY | ||||||
| 03/22/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/14/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $32.58 | General |
| 03/14/2022 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Neuroscience | ||||||
| 03/10/2022 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $86.40 | General |
| Category: Neurology | ||||||
| 03/10/2022 | Banner Life Sciences, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Immune | ||||||
| 03/09/2022 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| Category: Neurology | ||||||
| 03/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: PRIMARY CARE | ||||||
| 03/03/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.79 | General |
| 03/02/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Neuroscience | ||||||
| 02/26/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/22/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/21/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.89 | General |
| 02/11/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Neuroscience | ||||||
| 02/07/2022 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: EPILEPSY | ||||||
| 02/03/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Rare Disease | ||||||
| 02/02/2022 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Neurology | ||||||
| 02/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 745 | 913 | $305,978 | $44,356 |
| 2022 | 8 | 546 | 672 | $233,715 | $43,034 |
| 2021 | 6 | 274 | 411 | $145,818 | $31,944 |
Total Patients
1,565
Total Services
1,996
Medicare Billing
$119,334
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 74 | 103 | $60,788 | $10,946 | 18.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 65 | $38,612 | $6,920 | 17.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 48 | 48 | $37,824 | $6,038 | 16.0% |
| 92060 | Exam to measure eye deviation and range of motion | Facility | 2023 | 113 | 152 | $38,152 | $4,013 | 10.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $19,700 | $3,121 | 15.8% |
| 92083 | Exam of visual field with extended testing | Facility | 2023 | 118 | 153 | $27,846 | $3,027 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 44 | $17,836 | $3,014 | 16.9% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 71 | 91 | $22,841 | $2,393 | 10.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 68 | 76 | $13,832 | $1,496 | 10.8% |
| 92133 | Imaging of optic nerve | Facility | 2023 | 72 | 84 | $13,104 | $1,322 | 10.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 17 | $7,063 | $1,197 | 17.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 33 | 35 | $5,460 | $552.16 | 10.1% |
| 92250 | Photography of the retina | Facility | 2023 | 18 | 20 | $2,920 | $317.54 | 10.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 106 | $60,419 | $12,622 | 20.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 40 | 40 | $28,640 | $5,704 | 19.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 30 | 44 | $23,442 | $4,968 | 21.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $20,668 | $3,904 | 18.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 60 | 69 | $16,385 | $3,016 | 18.4% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 61 | 73 | $13,809 | $2,636 | 19.1% |
| 92060 | Exam to measure eye deviation and range of motion | Facility | 2022 | 66 | 81 | $18,468 | $2,283 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 22 | $9,178 | $1,928 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 23 | $8,411 | $1,747 | 20.8% |
| 92250 | Photography of the retina | Office | 2022 | 44 | 52 | $13,678 | $1,431 | 10.5% |
| 92083 | Exam of visual field with extended testing | Facility | 2022 | 57 | 66 | $10,890 | $1,356 | 12.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 21 | 28 | $3,763 | $741.02 | 19.7% |
About Devon Cohen
Devon Cohen is a Neuro-ophthalmology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1508229428.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Devon Cohen has received a total of $1,851 in payments from pharmaceutical and medical device companies, with $187.32 received in 2024. These payments were reported across 75 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,851).
As a Medicare-enrolled provider, Cohen has provided services to 1,565 Medicare beneficiaries, totaling 1,996 services with total Medicare billing of $119,334. Data is available for 3 years (2021–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuro-ophthalmology
- Other Specialties Neurology, Neurology
- Location Cleveland, OH
- Active Since 03/29/2016
- Last Updated 09/07/2022
- Taxonomy Code 207WX0109X
- Entity Type Individual
- NPI Number 1508229428
Products in Payments
- NURTEC ODT (Drug) $410.19
- UPLIZNA (Biological) $166.81
- UBRELVY (Drug) $114.20
- TYSABRI (Biological) $104.43
- EMGALITY (Drug) $99.10
- BOTOX (Biological) $86.91
- AUBAGIO (Drug) $79.11
- QULIPTA (Drug) $71.57
- VYEPTI (Biological) $66.13
- AJOVY (Biological) $56.20
- Fycompa (Drug) $55.15
- VALTOCO (Drug) $46.73
- Aimovig (Biological) $38.70
- Ponvory (Drug) $38.59
- BAFIERTAM (Drug) $32.77
- KESIMPTA (Drug) $27.83
- Soliris (Drug) $23.81
- APOKYN (Drug) $22.69
- XIIDRA (Drug) $21.67
- SOLIRIS (Biological) $21.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.